Hand and upper extremity transplantation: an update of outcomes in the worldwide experience.
Jaimie T Shores, Gerald Brandacher, W P Andrew Lee
https://pubmed.ncbi.nlm.nih.gov/25401735/Actively Recruiting
Led by Johns Hopkins University · Updated on 2026-05-11
60
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying the long-term outcomes of upper extremity allotransplantation, a procedure where a transplanted hand or arm is attached to a patient. This research is important to monitor the safety of the surgery and the immunosuppressive treatments used to prevent rejection. The study aims to collect ongoing data to better understand patient quality of life and functional outcomes following this complex transplant. The study involves follow-up assessments of patients who have undergone unilateral or bilateral upper limb transplantation at least five years prior. Participants agree to ongoing monitoring, including sample collection like biopsies, and adherence to immunomodulatory treatment plans. The research team evaluates various measures of hand function, psychological well-being, and physical health over approximately five years post-enrollment. Participants will have regular evaluations using questionnaires assessing hand function, pain, psychological health, and quality of life. Additional tests include antibody monitoring, skin biopsies, CT angiography, and MR neurography, performed annually for five years. These assessments help researchers track changes from baseline to understand the impact of transplantation and treatments. Patient commitment to the protocol and immunosuppressive therapy is required throughout the study period.
CONDITIONS
Human Upper Extremity Allotransplantation: F/U Protocol
J
Jane Littleton, C.R.N.P
T
TBD TBD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Johns Hopkins University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 5 years post-enrollment (±90 days)
Participants who have received unilateral or bilateral upper limb transplants are observed and assessed to monitor quality of life and transplant health over time.
Annual visits for up to 5 years
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Jaimie T Shores, Gerald Brandacher, W P Andrew Lee
https://pubmed.ncbi.nlm.nih.gov/25401735/Jaimie T Shores, Veronika Malek, W P Andrew Lee...
https://pubmed.ncbi.nlm.nih.gov/28361279/Brittany L Adler, Jemima Albayda, Jamie T Shores...
https://pubmed.ncbi.nlm.nih.gov/28654973/Johns Hopkins University
Lead Sponsor